Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis

APMIS

Volumn 119, Issue 7, 2011, Pages 412-420

  Söderberg, Cecilia ^a   Marmur, Joel ^b   Eckes, Kristina ^a   Glaumann, Hans ^c   Sällberg, Matti ^a   Frelin, Lars ^a   Rosenberg, Peter ^a   Stål, Per ^a   Hultcrantz, Rolf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Ersta Diakoni   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Foxp3; ICAM 1; Inflammation; NASH; Treg

Indexed keywords

CD3 ANTIGEN; CD68 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LIPID STORAGE; LIVER BIOPSY; LIVER CELL; LIVER CELL DAMAGE; MALE; MORPHOMETRICS; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC STEATOHEPATITIS ACTIVITY SCORING SYSTEM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; SCORING SYSTEM;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; APOPTOSIS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATS; FATTY LIVER; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEPATOCYTES; HUMANS; IMMUNITY, INNATE; INTERCELLULAR ADHESION MOLECULE-1; LIVER; MACROPHAGES; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY;

EID: 79958093929     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2011.02746.x     Document Type: Article

References (28)

1. Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010;51:595-602.
2. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-5.
3. Larter CZ, Chitturi S, Heydet D, Farrell GC. A fresh look at NASH pathogenesis. Part 1: the metabolic movers. J Gastroenterol Hepatol 2010;25:672-90.
4. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003;125:437-43.
5. Hubscher SG. Histological assessment of non-alcoholic fatty liver disease. Histopathology 2006;49:450-65.
6. Burra P, Hubscher SG, Shaw J, Elias E, Adams DH. Is the intercellular adhesion molecule-1/leukocyte function associated antigen 1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis? Gut 1992;33:268-71.
7. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. The Journal of Clinical Investigation 2006;116:3015-25.
8. Chang KM. Regulatory T cells and the liver: a new piece of the puzzle. Hepatology 2005;41:700-2.
9. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, et al. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004;40:1062-71.
10. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005;41:771-8 (Baltimore, MD).
11. Yoshizawa K, Abe H, Kubo Y, Kitahara T, Aizawa R, Matsuoka M, et al. Expansion of CD4(+)CD25(+)FoxP3(+) regulatory T cells in hepatitis C virus-related chronic hepatitis, cirrhosis and hepatocellular carcinoma. Hepatol Res 2010;40:179-87.
12. Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 2005;41:722-30.
13. Ferri S, Longhi MS, De Molo C, Lalanne C, Muratori P, Granito A, et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010;52:999-1007.
14. Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 2004;41:31-7.
15. Lapierre P, Beland K, Martin C, Alvarez F Jr, Alvarez F. Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis. Hepatology 2010;51:1789-98.
16. Lan RY, Cheng C, Lian ZX, Tsuneyama K, Yang GX, Moritoki Y, et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006;43:729-37.
17. Demirkiran A, Kok A, Kwekkeboom J, Kusters JG, Metselaar HJ, Tilanus HW, et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl 2006;12:277-84.
18. Bosanska L, Michalsky D, Lacinova Z, Dostalova I, Bartlova M, Haluzikova D, et al. The influence of obesity and different fat depots on adipose tissue gene expression and protein levels of cell adhesion molecules. Physiol Res 2009;59:79-88.
19. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21.
20. Weibel ER, Losa G, Bolender RP. Stereological method for estimating relative membrane surface area in freeze-fracture preparations of subcellular fractions. J Microsc 1976;107:255-66.
21. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with image. J Biophotonics International 2004;11:36-42.
22. Syn WK, Choi SS, Diehl AM. Apoptosis and cytokines in non-alcoholic steatohepatitis. Clin Liver Dis 2009;13:565-80.
23. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-54.
24. Sookoian S, Castano GO, Burgueno AL, Rosselli MS, Gianotti TF, Mallardi P, et al. Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease. Atherosclerosis 2010;209:585-91.
25. Nijhuis J, van Dielen FM, Fouraschen SM, van den Broek MA, Rensen SS, Buurman WA, et al. Endothelial activation markers and their key regulators after restrictive bariatric surgery. Obesity 2007;15:1395-9 (Silver Spring, MD).
26. Ito S, Yukawa T, Uetake S, Yamauchi M. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Alcohol Clin Exp Res 2007;31(1 Suppl):S83-7.
27. Douds AC, Lim AG, Jazrawi RP, Finlayson C, Maxwell JD. Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity. J Hepatol 1997;26:280-6.
28. Ruiz AG, Casafont F, Crespo J, Cayon A, Mayorga M, Estebanez A, et al. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 2007;17:1374-80.